The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion
Official Title: A Multicenter, Open-Label, Phase 2 Trial of E7090 in Subjects With Unresectable Advanced or Metastatic Cholangiocarcinoma With FGFR 2 Gene Fusion
Study ID: NCT04238715
Brief Summary: The primary purpose of the study is to assess the objective response rate (ORR) of E7090 by Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 based on independent imaging review (IIR) in participants with unresectable cholangiocarcinoma with FGFR2 gene fusion who failed gemcitabine-based combination chemotherapy.
Detailed Description:
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
Anhui Provincial Hospital, Hefei, Anhui, China
Beijing Tsinghua Chang Gung Memorial Hospital, Beijing, Beijing, China
Beijing Youan Hospital Affiliated to Capital Medical University, Beijing, Beijing, China
Beijng Cancer Hospital, Beijing, Beijing, China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Peking Union Medical University Hospital, Beijing, Beijing, China
Fujian Provincial Hospital, Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Guangdong Province Traditional Chinese Medical Hospital, Guangzhou, Guangdong, China
The First Affiliated Hospital, Sun Yat-sen Univeristy, Guangzhou, Guangdong, China
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Affiliated Hospital of Hebei University, Baoding, Hebei, China
Affilicataed Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang, China
Henan Cancer Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Hunan provincial people's hospital, Changsha, Hunan, China
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Xiangya Hospital of Central South University, Changsha, Hunan, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
Nantong Tumor Hospital, Nantong, Jiangsu, China
The First Affiliated Hospital of Soochow, Suzhou, Jiangsu, China
Jilin Cancer Hospital, Changchun, Jilin, China
Shandong Cancer Hospital, Jinan, Shandong, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Ningbo First Hospital, Ningbo, Zhejiang, China
Eisai Trial Site 10, Nagoya, Aichi, Japan
Eisai Trial Site 16, Kashiwa, Chiba, Japan
Eisai Trial Site 11, Matsuyama, Ehime, Japan
Eisai Trial Site 14, Matsuyama, Ehime, Japan
Eisai Trial Site 2, Sapporo, Hokkaido, Japan
Eisai Trial Site 8, Kanazawa, Ishikawa, Japan
Eisai Trial Site 7, Yokohama, Kanagawa, Japan
Eisai Trial Site 23, Tsu, Mie, Japan
Eisai Trial Site 22, Sendai, Miyagi, Japan
Eisai Trial Site 13, Hirakata, Osaka, Japan
Eisai Trial Site 17, Suita, Osaka, Japan
Eisai Trial Site 9, Sunto-gun, Shizuoka, Japan
Eisai Trial Site 5, Bunkyo-ku, Tokyo, Japan
Eisai Trial Site 4, Chuo-ku, Tokyo, Japan
Eisai Trial Site 6, Koto-ku, Tokyo, Japan
Eisai Trial Site 3, Mitaka, Tokyo, Japan
Eisai Trial Site 1, Ube-Shi, Yamaguchi, Japan
Eisai Trial Site 18, Chiba, , Japan
Eisai Trial Site 15, Fukuoka, , Japan
Eisai Trial Site 20, Kagoshima, , Japan
Eisai Trial Site 19, Kochi, , Japan
Eisai Trial Site 12, Kyoto, , Japan
Eisai Trial Site 21, Niigata, , Japan
Eisai Trial Site 24, Wakayama, , Japan